NVCRNovoCure Limited

$1B

Q3 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$50M+131.2% YoY

Gross Profit

$35M69.8% margin

Operating Income

-$6M-11.8% margin

Net Income

-$11M-22.9% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+30.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$795,000

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$262M

Total Liabilities

$146M

Stockholders' Equity

$117M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$22M	+131.2%
Gross Profit	$35M	$11M	+231.1%
Operating Income	-$6M	-$28M	+79.1%
Net Income	-$11M	-$34M	+65.8%

Geographic Segments

UNITED STATES

$35M70%

E M E A

$15M29%

JAPAN

$52,0000%

NVCR Q3 2017 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena